Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 33 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 7507826

    Azaindoles useful as inhibitors of JAK and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 24, 2009 · Expires Mar 19, 2029

    granted

  2. US 7504515

    Polymorphic forms of (S)-1-cyanobutan-2-yl (S)-1-(3-(3-(3-methoxy-4- (oxazol-5-yl)phenyl) ureido)phenyl) ethylcarbamate

    Vertex Pharmaceuticals Incorporated · Granted Mar 17, 2009 · Expires Mar 12, 2029

    granted

  3. US 7501415

    Selective inhibitors of ERK protein kinase and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Mar 10, 2009 · Expires Mar 5, 2029

    granted

  4. US 7495103

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted

  5. US 7494988

    Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted

  6. US 7495014

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted

  7. US 7494660

    HCV NS3-NS4A protease resistance mutants

    Vertex Pharmaceuticals Incorporated · Granted Feb 24, 2009 · Expires Feb 19, 2029

    granted

  8. US 7491730

    Compositions useful as inhibitors of GSK-3

    Vertex Pharmaceuticals Incorporated · Granted Feb 17, 2009 · Expires Feb 12, 2029

    granted

  9. US 7488727

    Thiazole compounds useful as inhibitors of protein kinase

    Vertex Pharmaceuticals Incorporated · Granted Feb 10, 2009 · Expires Feb 5, 2029

    granted

  10. US 7485664

    Inhibitors of TACE

    Vertex Pharmaceuticals Incorporated · Granted Feb 3, 2009 · Expires Jan 29, 2029

    granted

  11. US 7465738

    Compounds useful as promoters of SMN2

    Vertex Pharmaceuticals Incorporated · Granted Dec 16, 2008 · Expires Dec 11, 2028

    granted

  12. US 7462612

    Pyridine inhibitors of ERK2 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  13. US 7456190

    Compositions useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Nov 25, 2008 · Expires Nov 20, 2028

    granted

  14. US 7452873

    Inhibitors of GSK-3 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 18, 2008 · Expires Nov 13, 2028

    granted

  15. US 7446199

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted

  16. US 7446112

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Nov 4, 2008 · Expires Oct 30, 2028

    granted

  17. US 7442718

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted

  18. US 7442790

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted

  19. US 7439249

    Inhibitors of phosphatases

    Vertex Pharmaceuticals Incorporated · Granted Oct 21, 2008 · Expires Oct 16, 2028

    granted

  20. US 7432290

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted

  21. US 7432292

    Sulfhydantoins as phosphate isosteres

    Vertex Pharmaceuticals Incorporated · Granted Oct 7, 2008 · Expires Oct 2, 2028

    granted

  22. US 7427681

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted

  23. US 7423049

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2008 · Expires Sep 4, 2028

    granted

  24. US 7419967

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.